Poging GOUD - Vrij
'Equities poised for comeback in 2026 as growth improves'
Business Standard
|January 05, 2026
Banking, financial services and insurance (BFSI) stocks stand out currently with strong fundamentals and attractive valuations, says Ramesh Mantri, chief investment officer, WhiteOak Capital AMC.
-
In an interview with Abhishek Kumar in Mumbai, he adds that the outlook is also positive for the pharmaceutical and healthcare sector. Edited excerpts:
As the new year begins, how do you assess the equity market, and what are the key factors you will be watching closely?
It is difficult to predict near-term market movements. However, based on current trends, the equity market appears poised for a comeback in 2026.
Markets have largely remained range-bound since September 2024, indicating a time correction. At the same time, growth is showing early signs of improvement. Industrial activity has picked up, as reflected in strong November industrial production data, while inflation remains benign.
Lower inflation combined with improving growth is supportive for equities. Even the September quarter, which was expected to be weak due to tariff-related concerns and delayed GST benefits, turned out better than anticipated. Our asset allocation model had reduced equity exposure to its lowest level in the past two-and-a-half years around September 2024. Currently, it is around 10 per cent overweight on equities.
How important is the India-US trade deal as a trigger?
The deal should have been concluded by now, but it has been delayed. Beyond a point, it does not matter whether it happens in a few weeks or a couple of months, as long as the outcome is reasonable.
Dit verhaal komt uit de January 05, 2026-editie van Business Standard.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
